International Clinical Trial: Exploration of the efficacy and safety of suldaparin sodium vs. low molecular weight heparin sodium in preventing thrombotic events during the perioperative period of liver transplantation: A randomized controlled study

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117233) titled 'Exploration of the efficacy and safety of suldaparin sodium vs. low molecular weight heparin sodium in preventing thrombotic events during the perioperative period of liver transplantation: A randomized controlled study' on Jan. 21.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: West China Hospital, Sichuan University

Condition: Liver cirrhosis, liver cancer, etc

Intervention: Suldaparilla sodium group:Suldaparilla sodium is subcutaneously injected once, one vial per day

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-01

Target Sample Size: Suldap...